Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Linagliptin manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

linagliptin

Tablets 2.5 mg, 5 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Manufacturer #17643
This company specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates, focusing on cost-effective solutions with a strong emphasis on quality. They offer contract development and manufacturing services (CDMO) for both New Chemical Entities (NCEs) and APIs, leveraging their globally compliant GMP facilities and expertise in modified release technologies. The company boasts state-of-the-art production lines capable of handling high-potent materials across various scales, catering to a wide range of pharmaceutical products including prescription medications and potentially over-the-counter drugs. While specific therapy areas aren't mentioned, they hold patents for their innovations and are actively involved in research and development. Their operations span multiple regions, including North America and the EU.

Manufacturer usually replies in 2 days

linagliptin

Tablets 5 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #18975
This contract development and manufacturing organization (CDMO) specializes in producing a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, tablets, and capsules. They cater to clients across the globe, with a strong presence in regions like the EU and North America. Their expertise spans several key therapy areas, utilizing various dosage forms such as oral solid dose. They prioritize quality assurance, adhering to strict GMP certifications and holding numerous product patents.

Manufacturer usually replies in 14 days

linagliptin

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
India
Manufacturer #16857
A pharmaceutical manufacturer with integrated capabilities in active pharmaceutical ingredients, intermediates, and finished formulations, supplying pharmaceutical products to global partners across key therapy areas such as diabetes, cardiac care, neurology, anti-bacterial and anti-fungal segments. The organisation highlights strong in-house R&D, backward integration into intermediates and APIs, and scalable manufacturing from development to multi-ton commercial output. For quality, the site states that its formulation manufacturing operates in a GMP-compliant facility recognised by major regulators, and specifically lists approvals/recognition including USFDA, EU-GMP, WHO and TGA, supporting reliable international supply of pharmaceutical products.

Manufacturer usually replies in 10 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is the Linagliptin drug?

Linagliptin is a DPP-4 inhibitor. Linagliptin works in two different ways; it helps the pancreas to produce more insulin and the liver to produce less sugar. The combination of those two actions lower the blood sugar in the patient. Linagliptin is a medication used to treat diabetes mellitus type 2; it works in addition to diet and exercise. The FDA in the US approved the medical use of the Linagliptin drug in 2011.

Linagliptin manufacturers and wholesalers:

Boehringer Ingelheim developed Linagliptin. One of its brand names is Tradjenta. Linagliptin suppliers market it in the form of a 5 mg oral film-coated tablet. Linagliptin is a globally found medication.

Linagliptin for sales:

In the US, Linagliptin's price is $16 per 5 mg tablet. For a month supply, the wholesale cost is about $391 whereas in the United Kingdom, for the same amount, one month, Linagliptin costs about £ 33.26.
On Pipelinepharma pharmaceutical market place, Linagliptin is most available from the European Union, India, and Bangladesh. The online platform helps the distributors to find qualified Linagliptin manufacturers globally, ensuring you they are not fraudulent websites. Using the integrated search engine of the marketplace, you can find a list of many pharmaceutical products for sale, including Linagliptin. Each Linagliptin manufacturer or supplier product description encompasses lots of information about the medication such as form, dose, manufacturing site approvals, and regulatory status. Then using the simple one-click contact form, you can enquire about the supply price if none are listed and place an order or send inquiries to companies no matter where they are in the world. Not only is this marketplace good news for distributors and other buyers, but wholesale sellers and manufacturers benefit as well. They can register and list an unlimited number of pharmaceutical products free of charge.

How to use Linagliptin drugs?

To treat diabetes - type 2, an adult patient should take 5 mg orally once a day. Linagliptin can be taken with or without food, but it is advised to take the medication at the same time of the day. Taking the Linagliptin drug can cause some side effects, such as anxiety, hypoglycemia, blurred vision, chills, cold sweats, confusion, and cool, pale skin. If patients had or have problems with their pancreas, they should not take Linagliptin. The Linagliptin must be stored at room temperature, away from humidity and heat. Keep it out of reach of children.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.